跳至主要内容
临床试验/NCT04591795
NCT04591795Unknown2 期

Efficacy and Safety of Sahastara Remedy Extract Capsules in Treating Primary Osteoarthritis of the Knee Compared With Diclofenac (Clinical Trial Phase II)

Mr NARIN KAKATUM1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
80
试验地点
1
主要终点
Pain score 1

研究概览

简要总结

To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac (Phase II).

详细描述

Sample size 66 volunteers

The patients were divided randomly into 2 treatment groups. The patients in group 1 received the SHT extract 300 mg/day (1 capsule of 100 mg SHT extract three times daily before meals). The patients in group 2 received diclofenac sodium 75 mg/day (1 capsule of 25 mg diclofenac three times daily after meals). In addition, the patients in both groups received 20 mg of omeprazole, 1 capsule before breakfast for protects of Gastrointestinal adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • No pregnancy
  • No Serious Medical Condition evaluated by Physical Examination and Laboratory results in 1 month before study
  • No Supplementary food and/or Vitamin during the study Able to follow suggestion during the study

排除标准

  • Uncontrolled Hypertension (BP>140/90 mm.Hg.) BMI > 30
  • Have serious medical condition including Severe peptic ulcer, congestive heart disease, Liver and Renal dysfunction.
  • On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline

研究组 & 干预措施

100 mg SHT extract

Experimental

Drug: Sahastara remedy alcoholic extract comparison with diclofenac

干预措施: Diclofenac (Drug)

25 mg dicolfenac

Experimental

Drug: diclofenac comparison with diclofenac

干预措施: Sahastara remedy extract (Drug)

结局指标

主要结局

Pain score 1

时间窗: 28 day

Pain score from Visual analog scale

次要结局

  • Pain score 2(28 day)

研究者

发起方
Mr NARIN KAKATUM
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mr NARIN KAKATUM

Faculty of Medicine

Thammasat University

研究点 (1)

Loading locations...

相似试验